CAPVAXIVE sol inj ser prérempl 4 µg 10 pce

7680697810026 CH-69781 J07AL02 08.08.

No images available

Details

Product number
6978101
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 9N conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 15A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 15B de-O-acetylatus conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 16F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 17F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 20A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 23A conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 23B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 24F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 31 conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, polysaccharida streptococci pneumoniae typus 35B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg, corresp. proteinum corynebacteriae diphtheriae CRM 197 65 µg, polysorbatum 20, histidinum, acidum hydrochloridum ad pH, natrii chloridum corresp. natrium 1.77 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml,

Articles (1)

Capvaxive, Injektionslösung in Fertigspritze
Injektionslösung in Fertigspritze
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/10/2025
Professional SmPC
Français
07/10/2025
Professional SmPC
Italien
07/10/2025

Detailed composition

Substance Quantity Type Category
polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 8 conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 9N conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 10A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 11A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 12F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 15A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 15B de-O-acetylatus conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 16F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 17F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 20A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 23A conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 23B conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 24F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 31 conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
polysaccharida streptococci pneumoniae typus 35B conjugata cum proteino corynebacteriae diphtheriae CRM 197
4.0 UG Substance Wirkstoff (Principe actif)
proteinum corynebacteriae diphtheriae CRM 197
65.0 UG Substance WIIS
polysorbatum 20
- Substance HNIDK
histidinum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
1.77 MG Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 710.70
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2026

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
69781
Drug name
Capvaxive, Injektionslösung in Fertigspritze
Galenic form
INLFS
ATC Code
J07AL02
Authorization status
Z
Dispensation category
B
First authorization
23/09/2025
Authorization expiration date
22/09/2030
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen der Serotypen 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, de-O-acetyliert 15B, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F, 35B

Packaging details

Description (FR)
CAPVAXIVE sol inj ser prérempl 4 µg 10 pce
Description (DE)
CAPVAXIVE Inj Lös Fertigspr 4 µg 10 Stk
Market launch
01/08/2026
Narcotic (BTM)
No

Other packaging sizes

CAPVAXIVE sol inj 4 µg 1 pce
1 FESP
View
Buy us a coffee Explore the data